Stay updated on Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Added a Locations section listing Texas as a study site and removed the separate Texas Locations footer entry; the HHS Vulnerability Disclosure link and the prior revision note were also removed.
    Difference
    0.2%
    Check dated 2025-12-22T23:48:53.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.1 to v3.3.2; no changes to study content or data are observed.
    Difference
    0.1%
    Check dated 2025-12-01T10:51:55.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    A small system revision update is visible at the bottom of the page, showing Revision: v3.3.1 added and Revision: v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:10:21.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Removed the government funding/operation status notice from the page, a non-critical housekeeping change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:09:24.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The screenshots show the same study page with no additions or deletions to core information. The page content appears unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T00:44:16.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    - Added a government funding operating-status notice and updated operating details for NIH Clinical Center (high importance). - Updated version from v3.1.0 to v3.2.0 (moderate importance).
    Difference
    4%
    Check dated 2025-10-05T04:57:47.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with REOLYSIN in Pancreatic Cancer Clinical Trial page.